NORTH STAR ASSET MANAGEMENT INC
Position in ATNM — Actinium Pharmaceuticals, Inc.
CIK 1056559
NEENAH, WI
Position in ATNM
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$19,900
-$7,300 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATNM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTH STAR ASSET MANAGEMENT INC holds $9,303,998 across 8 Biotechnology names. ATNM ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,859 | $3,062,817 | |
| 2 | EXEL |
Exelixis, Inc.
|
57,550 | $2,468,319 | |
| 3 | INCY |
Incyte Corp
|
14,408 | $1,356,080 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
16,610 | $1,247,244 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
737 | $569,435 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,103 | $364,949 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
4,525 | $215,254 | |
| 8 | ATNM |
Actinium Pharmaceuticals, Inc.
This page
|
20,000 | $19,900 |
All Filings in ATNM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,900 | 20,000 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $27,200 | 20,000 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $32,000 | 20,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $28,000 | 20,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $16,100 | 10,000 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $12,600 | 10,000 | Shares | Sole | 2025-02-19 | |
| No filing history on record for this holder in this stock. | ||||||